Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Actions of a picomolar short-acting S1P1 agonist in S1P1-eGFP knock-in mice

Nature Chemical Biology volume 7, pages 254–256 (2011)Cite this article

Subjects

Abstract

Sphingosine 1-phosphate receptor 1 (S1P1) is critical for lymphocyte recirculation and is a clinical target for treatment of multiple sclerosis. By generating a short-duration S1P1 agonist and mice in which fluorescently tagged S1P1 replaces wild-type receptor, we elucidate physiological and agonist-perturbed changes in expression of S1P1 at a subcellular level in vivo. We demonstrate differential downregulation of S1P1 on lymphocytes and endothelia after agonist treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: RP-001 is an orthosteric, short-duration S1P1 selective agonist.
Figure 2: Function of S1P1-eGFP in Edg1eGFP/eGFP mice.
Figure 3: RP-001 causes changes in lymphocytic and endothelial S1P1-eGFP expression and localization.

Similar content being viewed by others

References

  1. Okamoto, H. et al. J. Biol. Chem. 273, 27104–27110 (1998).

    Article  CAS  Google Scholar 

  2. Liu, Y. et al. J. Clin. Invest. 106, 951–961 (2000).

    Article  CAS  Google Scholar 

  3. Allende, M.L. & Proia, R.L. Biochim. Biophys. Acta 1582, 222–227 (2002).

    Article  CAS  Google Scholar 

  4. Sanna, M.G. et al. Nat. Chem. Biol. 2, 434–441 (2006).

    Article  CAS  Google Scholar 

  5. Matloubian, M. et al. Nature 427, 355–360 (2004).

    Article  CAS  Google Scholar 

  6. Sanna, M.G. et al. J. Biol. Chem. 279, 13839–13848 (2004).

    Article  CAS  Google Scholar 

  7. Gonzalez-Cabrera, P.J. et al. Mol. Pharmacol. 74, 1308–1318 (2008).

    Article  CAS  Google Scholar 

  8. Salvadori, M. et al. Am. J. Transplant. 6, 2912–2921 (2006).

    Article  CAS  Google Scholar 

  9. Mandala, S. et al. Science 296, 346–349 (2002).

    Article  CAS  Google Scholar 

  10. Gräler, M.H. & Goetzl, E.J. FASEB J. 18, 551–553 (2004).

    Article  Google Scholar 

  11. O'Connor, P. et al. Neurology 72, 73–79 (2009).

    Article  CAS  Google Scholar 

  12. Comi, G. et al. Mult. Scler. 16, 197–207 (2010).

    Article  CAS  Google Scholar 

  13. Kappos, L. et al. N. Engl. J. Med. 362, 387–401 (2010).

    Article  CAS  Google Scholar 

  14. Allende, M.L., Dreier, J.L., Mandala, S. & Proia, R.L. J. Biol. Chem. 279, 15396–15401 (2004).

    Article  CAS  Google Scholar 

  15. Liu, G. et al. Nat. Immunol. 10, 769–777 (2009).

    Article  CAS  Google Scholar 

  16. Wang, W., Huang, M.C. & Goetzl, E.J. J. Immunol. 178, 4885–4890 (2007).

    Article  CAS  Google Scholar 

  17. Thangada, S. et al. J. Exp. Med. 207, 1475–1483 (2010).

    Article  CAS  Google Scholar 

  18. Mullershausen, F. et al. Nat. Chem. Biol. 5, 428–434 (2009).

    Article  CAS  Google Scholar 

  19. Grigorova, I.L. et al. Nat. Immunol. 10, 58–65 (2009).

    Article  CAS  Google Scholar 

  20. Wei, S.H. et al. Nat. Immunol. 6, 1228–1235 (2005).

    Article  CAS  Google Scholar 

  21. Igarashi, J. & Michel, T. J. Biol. Chem. 275, 32363–32370 (2000).

    Article  CAS  Google Scholar 

  22. Pham, T.H. et al. J. Exp. Med. 207, 17–27 (2010).

    Article  CAS  Google Scholar 

  23. Van Doorn, R. et al. Glia 58, 1465–1476 (2010).

    Article  Google Scholar 

  24. Marsolais, D. et al. Mol. Pharmacol. 74, 896–903 (2008).

    Article  CAS  Google Scholar 

  25. Marsolais, D. et al. Proc. Natl. Acad. Sci. USA 106, 1560–1565 (2009).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge R. Proia and M. Capecchi for providing plasmids used in the generation of the Edg1eGFP targeting construct. We thank G. Martin and S. Kupriyanov for aid in generating Edg1eGFP/eGFP mice. We thank B. Webb for aid with mass spectrometry. S.M.C. is supported by a US National Institutes of Health Immunology Training Grant T32 AI007606. H.R. is supported by US National Institutes of Health Grants NIH U01 AI074564, R01 AI055509 and U54 MH084512.

Author information

Authors and Affiliations

  1. Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California, USA

    Stuart M Cahalan, Pedro J Gonzalez-Cabrera, Nhan Nguyen, Marie-Therese Schaeffer & Hugh Rosen

  2. Department of Immunology, The Scripps Research Institute, La Jolla, California, USA

    Stuart M Cahalan, Gor Sarkisyan & Hugh Rosen

  3. Receptos Pharmaceuticals Inc., La Jolla, California, USA

    Liming Huang, Adam Yeager, Bryan Clemons & Fiona Scott

Authors
  1. Stuart M Cahalan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pedro J Gonzalez-Cabrera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gor Sarkisyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nhan Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marie-Therese Schaeffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Liming Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Adam Yeager
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bryan Clemons
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Fiona Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hugh Rosen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S.M.C. and H.R. designed the experiments and wrote the manuscript. S.M.C. generated the S1P1-eGFP knock-in mice and performed the in vivo experiments and flow cytometric analysis. P.J.G.-C. and N.N. performed biochemical experiments. G.S. performed two-photon experiments. M.-T.S. performed in vitro characterization of RP-001 and W146 competition. L.H. and A.Y. synthesized RP-001. B.C. and F.S. performed in vitro characterization of RP-001.

Corresponding author

Correspondence to Hugh Rosen.

Ethics declarations

Competing interests

H.R. is scientific co-founder of Receptos Pharmaceuticals.

Supplementary information

Supplementary Text and Figures

Supplementary Methods, Supplementary Scheme 1, Supplementary Tables 1–3 and Supplementary Figures 1–12 (PDF 2779 kb)

Supplementary Video 1

Intravital two-photon imaging of a Edg1eGFP/eGFP lymph node cortex (MOV 2855 kb)

Supplementary Video 2

Extravital two-photon imaging of lymph nodes from Edg1eGFP/eGFP mice in response to vehicle treatment (MOV 7212 kb)

Supplementary Video 3

Extravital two-photon imaging of lymph nodes from Edg1eGFP/eGFP mice in response to RP-001 treatment (MOV 1085 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cahalan, S., Gonzalez-Cabrera, P., Sarkisyan, G. et al. Actions of a picomolar short-acting S1P1 agonist in S1P1-eGFP knock-in mice. Nat Chem Biol 7, 254–256 (2011). https://doi.org/10.1038/nchembio.547

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio.547

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing